Herbal Medicine Market Size, Share, Growth, and Industry Analysis, By Type (Tablets & Capsules,Powders,Extracts,Others), By Application (Western Herbalism,Traditional Chinese Medicine,Others), Regional Insights and Forecast to 2035

Herbal Medicine Market Overview

The global Herbal Medicine Market size is projected to grow from USD 2037.76 million in 2026 to USD 2117.85 million in 2027, reaching USD 181120.66 million by 2035, expanding at a CAGR of 3.93% during the forecast period.

The Herbal Medicine Market is a rapidly evolving sector of the healthcare industry with widespread adoption across pharmaceutical, nutraceutical, and wellness categories. In 2024, the global herbal medicine market size was valued at approximately USD 225 billion, reflecting strong growth compared to USD 210 billion in 2022. Herbal medicine currently represents nearly 20% of the global alternative medicine sector, serving over 5.2 billion people worldwide who rely on plant-based formulations for primary or supplementary treatment. The industry is segmented by type, application, and region. By formulation, tablets and capsules dominate with around 45% share of the market, while powders account for nearly 25%, extracts close to 20%, and other forms like ointments and teas hold about 10%. In terms of ingredients, roots and barks contribute approximately 38% of raw material usage, followed by leaves at 35%, seeds and fruits at 18%, and flowers at 9%.

Geographically, Asia-Pacific leads the global herbal medicine industry with nearly 43% market share, supported by the strong presence of Traditional Chinese Medicine (TCM), Ayurveda, and Japanese Kampo practices. Europe follows closely with about 29% share, led by Germany, France, and the United Kingdom, which collectively account for over 65% of the European segment. North America holds nearly 18%, while the Middle East & Africa together contribute around 10%, showing rising adoption in the Gulf countries and South Africa. The consumer base is expanding rapidly, with more than 65% of adults in developed economies reporting regular use of herbal products for preventive or therapeutic purposes. The market is also influenced by digital distribution, with online channels representing about 35% of total sales in 2024, compared to 22% in 2020. This trend demonstrates the acceleration of e-commerce penetration in the herbal medicine industry.

The USA herbal medicine market is one of the fastest-growing within North America, with the market size crossing USD 40 billion in 2024, up from USD 35 billion in 2022. Herbal supplements are used by nearly 35% of American adults, which translates to more than 120 million individuals incorporating botanicals into their daily healthcare routines. By type, tablets and capsules account for about 48% of the U.S. market share, with powders holding 22%, extracts 20%, and other forms such as ointments and teas taking 10%. Among applications, Western Herbalism dominates with nearly 60% share, Traditional Chinese Medicine (TCM) contributes around 25%, and other global traditions such as Ayurveda and Kampo represent the remaining 15%. The retail distribution of herbal products in the U.S. is shifting significantly toward online platforms, which now account for 33% of total sales compared to 20% just three years earlier. California, Texas, and New York are the top three contributing states, together holding nearly 40% of the U.S. herbal medicine industry. The growing emphasis on wellness and preventive healthcare, along with rising demand for clean-label products, continues to position the United States as a crucial player in the global herbal medicine market outlook.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Driver: About 62% of consumers prefer natural remedies over synthetic pharmaceuticals, driving growth in the herbal medicine market.
• Major Market Restraint: Nearly 37% of herbal formulations face regulatory or quality standardization challenges worldwide.
• Emerging Trends: Around 49% of new product launches focus on herbal immunity boosters and adaptogenic supplements.
• Regional Leadership: Asia-Pacific accounts for nearly 43% of total herbal medicine market share globally.
• Competitive Landscape: The top 10 companies collectively control about 28% of global herbal medicine sales.
• Market Segmentation: Tablets and capsules dominate with nearly 45% market share across product types.
• Recent Development: Over 55% of product innovations between 2023 and 2025 are driven by e-commerce demand and direct-to-consumer sales.

Herbal Medicine Market Trends

The Herbal Medicine Market Trends highlight significant shifts in consumer behavior, product development, and regional adoption. One of the strongest trends is the increasing demand for immunity-boosting herbal formulations. Since 2020, sales of herbal immunity supplements have grown by nearly 60%, with adaptogenic herbs such as ashwagandha, ginseng, and turmeric seeing accelerated adoption. Personalization is another dominant trend, with approximately 27% of global herbal supplement users now opting for customized formulations. DNA-based wellness programs that integrate herbal treatments are projected to reach nearly 10 million users worldwide by 2026. The integration of digital health platforms with herbal products has also grown rapidly.

Nearly 32% of herbal medicine buyers now purchase products through online subscription services, reflecting a strong alignment between e-commerce and natural healthcare. Sustainability is a rising priority, with more than 45% of consumers preferring herbal medicines sourced from certified organic farms. This has pushed manufacturers to invest in sustainable agriculture practices and traceable supply chains. Furthermore, herbal cosmetic and beauty products are merging with the mainstream herbal medicine market, with this category growing at an annual pace of nearly 12% and accounting for USD 30 billion in 2024. Herbal beverages, including teas and tonics, are experiencing double-digit growth, with global consumption surpassing 600,000 tons annually. Countries such as China and India dominate production, while North America and Europe are emerging as major consumption hubs.

Herbal Medicine Market Dynamics

DRIVER

"Rising demand for pharmaceuticals."

Herbal medicines are being increasingly used as complementary alternatives to pharmaceutical drugs, with 62% of consumers worldwide preferring natural treatment options. Rising cases of chronic illnesses, which account for over 70% of global deaths annually, are driving demand for safer, plant-based solutions. The integration of herbal therapies into mainstream healthcare systems has created opportunities for manufacturers to serve a global patient base exceeding 5 billion people.

RESTRAINT

"Demand for refurbished equipment."

Despite growth, the market faces restraints in the form of quality standardization and regulatory barriers. Approximately 37% of herbal products tested in 2024 showed inconsistencies in active ingredient concentration. This lack of global regulatory harmonization creates consumer safety concerns, slowing adoption in developed economies. Additionally, nearly 15% of herbal imports in Europe faced rejection due to labeling or safety violations, highlighting the scale of the problem.

OPPORTUNITY

"Growth in personalized medicines."

The demand for personalized herbal formulations is surging, with nearly 27% of consumers seeking tailored supplements. Genomics-based personalization is projected to reach over 100 million consumers by 2030, creating opportunities for manufacturers to combine AI-driven diagnostics with herbal formulations. This shift presents potential growth in functional wellness, mental health, and anti-aging applications.

CHALLENGE

"Rising costs and expenditures."

Supply chain disruptions and increased farming costs have raised raw material prices by nearly 18% in the past three years. Rare herbs such as saffron and ginseng have seen price hikes of over 25%, making affordability a challenge for end users. Additionally, counterfeit herbal products, which account for nearly 12% of market circulation in some regions, continue to undermine brand credibility and consumer trust.

Herbal Medicine Market Segmentation

The Herbal Medicine Market Segmentation is based on type and application.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Tablets & Capsules: This category accounts for nearly 45% of the global herbal medicine market share. With dosage precision and convenience, tablets and capsules are widely adopted, particularly in North America and Europe. Annual consumption is estimated at over 20 billion units worldwide.

The tablets & capsules segment in the herbal medicine market is projected to hold USD 55,428.60 million in 2025, increasing to USD 79,482.35 million by 2034 at a 4.05% CAGR, representing 45% market share.

Top 5 Major Dominant Countries in the Tablets & Capsules Segment

• United States holds USD 15,342.88 million market size with 27.68% share and 4.10% CAGR, supported by strong demand for herbal dietary supplements.
• China accounts for USD 11,402.30 million market size with 20.56% share and 4.20% CAGR, driven by Traditional Chinese Medicine-based capsule innovations.
• Germany represents USD 8,321.54 million market size with 15.01% share and 3.85% CAGR, reflecting its physician-prescribed phytomedicine culture.
• India stands at USD 7,204.15 million market size with 12.99% share and 4.25% CAGR, benefiting from Ayurveda-based capsule formulations.
• Japan contributes USD 6,532.25 million market size with 11.78% share and 3.95% CAGR, led by Kampo herbal capsules adoption.

Powders: hold about 25% share of the herbal medicine industry. They are highly popular in Asia-Pacific, where Ayurvedic and TCM practices rely on powdered herbs for decoctions and tonics. Global demand exceeds 12 million tons annually.

The powders segment is expected to record USD 30,793.67 million in 2025, reaching USD 41,921.15 million by 2034 at a 3.55% CAGR, representing 25% share of the global herbal medicine market.

Top 5 Major Dominant Countries in the Powders Segment

• China dominates with USD 9,237.12 million size, 29.99% share and 3.60% CAGR, led by traditional powdered herbal decoctions.
• India holds USD 7,853.43 million size, 25.50% share and 3.75% CAGR, reflecting Ayurveda powders in wellness and preventive care.
• United States accounts for USD 5,210.44 million size, 16.91% share and 3.40% CAGR, with powders integrated in nutraceuticals.
• Germany stands at USD 4,205.60 million size, 13.65% share and 3.25% CAGR, with powders widely sold through pharmacies.
• Brazil records USD 2,987.08 million size, 9.71% share and 3.55% CAGR, showcasing rapid growth in herbal powders for teas.

Extracts: represent nearly 20% of market share. Standardized herbal extracts such as ginkgo biloba, echinacea, and valerian are widely used in functional supplements. Approximately 60% of pharmaceutical-grade herbal formulations use concentrated extracts.

The extracts segment is valued at USD 24,634.94 million in 2025, projected to grow to USD 34,796.72 million by 2034 at a 4.02% CAGR, representing 20% market share.

Top 5 Major Dominant Countries in the Extracts Segment

• Germany holds USD 6,542.28 million market size with 26.56% share and 4.00% CAGR, driven by standardized herbal extracts.
• United States accounts for USD 5,210.22 million size with 21.15% share and 4.05% CAGR, reflecting growing use in functional supplements.
• China represents USD 4,916.56 million size with 19.96% share and 4.20% CAGR, supported by TCM extract formulations.
• India contributes USD 4,110.95 million size with 16.68% share and 4.10% CAGR, boosted by Ayurveda-based extracts.
• France records USD 3,855.04 million size with 15.65% share and 3.85% CAGR, reflecting extract integration in nutraceuticals.

Others: forms, including ointments, teas, and herbal oils, collectively contribute about 10%. Herbal teas alone account for annual global consumption exceeding 600,000 tons, highlighting their popularity in preventive healthcare.

The “others” category, which includes herbal oils, teas, ointments, and topical forms, holds USD 12,317.47 million in 2025, expected to reach USD 18,071.56 million by 2034 at a 3.67% CAGR, accounting for 10% share.

Top 5 Major Dominant Countries in the Others Segment

• China accounts for USD 3,325.26 million size, 26.99% share and 3.70% CAGR, fueled by herbal teas and ointments.
• India holds USD 2,712.74 million size, 22.02% share and 3.85% CAGR, driven by Ayurvedic oils and balms.
• United States represents USD 2,154.11 million size, 17.48% share and 3.50% CAGR, with oils and ointments in personal care.
• Germany records USD 1,972.62 million size, 16.02% share and 3.60% CAGR, due to demand for essential oils.
• Brazil contributes USD 1,641.21 million size, 13.49% share and 3.70% CAGR, supported by local herbal teas.

BY APPLICATION

Western Herbalism: medicine dominates with about 50% share globally. Common herbs include peppermint, echinacea, and chamomile, consumed by over 200 million people in Europe and North America.

Western herbalism is valued at USD 61,587.34 million in 2025, projected to reach USD 87,135.89 million by 2034 at a 3.96% CAGR, holding 50% share.

Top 5 Major Dominant Countries in Western Herbalism

• United States holds USD 18,476.20 million size with 29.98% share and 4.05% CAGR, being the largest Western herbal market.
• Germany represents USD 12,315.62 million size with 19.99% share and 3.90% CAGR, led by physician-prescribed phytomedicines.
• France holds USD 10,478.38 million size with 17.01% share and 3.85% CAGR, supported by nutraceutical consumption.
• United Kingdom contributes USD 9,238.11 million size with 15.00% share and 3.80% CAGR, reflecting growing herbal dietary use.
• Canada accounts for USD 8,079.02 million size with 13.12% share and 3.95% CAGR, reflecting strong nutraceutical adoption.

Traditional Chinese Medicine: contributes nearly 30% of the market share. China alone employs over 13,000 documented herbal species, with more than 100 million TCM prescriptions issued annually.

The Traditional Chinese Medicine segment is expected at USD 36,952.40 million in 2025, rising to USD 52,281.53 million by 2034 at a 3.95% CAGR, contributing 30% share.

Top 5 Major Dominant Countries in Traditional Chinese Medicine

• China dominates with USD 18,476.20 million size, 49.98% share and 4.00% CAGR, due to nationwide integration of TCM.
• Japan records USD 6,365.09 million size, 17.22% share and 3.90% CAGR, led by Kampo-based herbal formulations.
• South Korea contributes USD 5,543.69 million size, 15.00% share and 3.95% CAGR, with widespread Korean herbal medicine.
• United States holds USD 3,695.24 million size, 10.00% share and 4.05% CAGR, reflecting adoption of TCM therapies.
• Australia accounts for USD 2,772.18 million size, 7.50% share and 3.80% CAGR, driven by TCM imports.

Others: Ayurveda, Kampo, and African traditional medicine collectively hold around 20%. Ayurveda is practiced by nearly 500 million people in India, while Japanese Kampo is used by 70% of physicians in Japan.

This segment is valued at USD 24,634.94 million in 2025, projected to grow to USD 34,854.36 million by 2034 at a 3.92% CAGR, accounting for 20% share.

Top 5 Major Dominant Countries in Other Applications

• India leads with USD 11,098.72 million size, 45.07% share and 4.10% CAGR, being the global hub for Ayurveda.
• Japan contributes USD 4,187.95 million size, 17.00% share and 3.85% CAGR, with Kampo widely used.
• South Africa holds USD 3,448.89 million size, 14.00% share and 3.95% CAGR, supported by indigenous herbal traditions.
• Brazil represents USD 3,203.55 million size, 13.00% share and 3.90% CAGR, driven by Amazon-based herbs.
• Nigeria accounts for USD 2,695.83 million size, 11.00% share and 3.75% CAGR, due to traditional herbal medicine reliance.

Herbal Medicine Market Regional Outlook

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

holds nearly 18% of the global herbal medicine market share, valued at over USD 40 billion in 2024. The United States contributes about 85% of this share, while Canada accounts for 10% and Mexico about 5%. Western Herbalism dominates the region, with more than 120 million U.S. adults using herbal supplements. The U.S. leads in herbal capsules and extracts, which represent nearly 60% of sales. Online distribution accounts for about 33% of the North American herbal market, up from 22% in 2020. The strong wellness culture and integration of herbal remedies into functional foods continue to drive adoption.

The North American herbal medicine market is valued at USD 27,098.43 million in 2025, projected to reach USD 38,344.53 million by 2034 at a 3.97% CAGR, holding 22% share globally.

North America - Major Dominant Countries in the “Herbal Medicine Market”

• United States accounts for USD 20,323.82 million size with 74.99% share and 4.00% CAGR, leading in herbal supplements.
• Canada represents USD 4,064.76 million size with 14.99% share and 3.95% CAGR, supported by natural healthcare policies.
• Mexico holds USD 1,897.18 million size with 7.00% share and 3.85% CAGR, driven by herbal teas and remedies.
• Cuba records USD 450.67 million size with 1.66% share and 3.75% CAGR, reflecting state-driven herbal initiatives.
• Jamaica contributes USD 361.99 million size with 1.30% share and 3.70% CAGR, with local herbal medicine culture.

EUROPE

represents around 29% of the herbal medicine market share, led by Germany, France, and the UK, which together account for over 65% of the regional demand. In Germany alone, nearly 70% of physicians prescribe herbal medicines as part of standard care. Tablets and capsules dominate in Europe, with 52% share, while herbal teas and oils hold about 20%. The European Union regulates over 1,200 herbal medicinal products, ensuring strict quality and safety. The market is fueled by strong consumer demand, with more than 200 million Europeans using herbal products regularly.

Europe is valued at USD 35,720.65 million in 2025, expected to reach USD 49,220.25 million by 2034 at a 3.84% CAGR, representing 29% global share.

Europe - Major Dominant Countries in the “Herbal Medicine Market”

• Germany leads with USD 10,716.20 million size, 29.99% share and 3.85% CAGR, due to phytomedicine prescriptions.
• France holds USD 7,501.33 million size, 21.00% share and 3.80% CAGR, supported by herbal cosmetics.
• United Kingdom represents USD 6,078.51 million size, 17.02% share and 3.75% CAGR, with strong herbal supplement adoption.
• Italy accounts for USD 5,000.00 million size, 14.00% share and 3.70% CAGR, with herbal dietary uses.
• Spain contributes USD 4,116.61 million size, 11.99% share and 3.65% CAGR, reflecting herbal teas consumption.

ASIA-PACIFIC

is the global leader with nearly 43% of the market share, supported by Traditional Chinese Medicine, Ayurveda, and Kampo. China accounts for over 60% of regional consumption, India about 25%, and Japan 10%. More than 100 million TCM prescriptions are issued annually in China, and Ayurveda is used by over 500 million people in India. The region is also the largest exporter of raw herbal ingredients, with annual exports exceeding 8 million tons.

The Asia herbal medicine market stands at USD 53,964.86 million in 2025, projected to grow to USD 76,187.74 million by 2034 at a 4.03% CAGR, contributing 44% global share.

Asia - Major Dominant Countries in the “Herbal Medicine Market”

• China leads with USD 21,585.94 million size, 39.98% share and 4.10% CAGR, due to TCM dominance.
• India holds USD 15,229.16 million size, 28.22% share and 4.15% CAGR, driven by Ayurveda.
• Japan contributes USD 8,714.38 million size, 16.15% share and 3.90% CAGR, with Kampo popularity.
• South Korea records USD 5,396.49 million size, 10.00% share and 3.95% CAGR, led by traditional medicine.
• Indonesia represents USD 3,038.89 million size, 5.63% share and 3.85% CAGR, with herbal product demand.

MIDDLE EAST & AFRICA

together hold about 10% of the global herbal medicine market. In the Middle East, Saudi Arabia, UAE, and Egypt lead adoption, contributing nearly 65% of regional demand. In Africa, South Africa is the largest market, accounting for 35% of herbal medicine usage. Traditional African medicine, which relies on over 3,000 documented plant species, is practiced by nearly 80% of the population. The region is seeing rising adoption of herbal teas, oils, and powders. Distribution remains fragmented, with 70% of sales occurring through local markets and herbal practitioners.

The Middle East & Africa market is estimated at USD 6,390.74 million in 2025, projected to reach USD 8,519.26 million by 2034 at a 3.31% CAGR, holding 5% share globally.

Middle East and Africa - Major Dominant Countries in the “Herbal Medicine Market”

• Saudi Arabia leads with USD 1,726.35 million size, 27.00% share and 3.35% CAGR, driven by herbal wellness centers.
• South Africa holds USD 1,597.68 million size, 25.00% share and 3.30% CAGR, due to indigenous medicine reliance.
• UAE accounts for USD 958.61 million size, 15.00% share and 3.25% CAGR, with rising herbal imports.
• Egypt contributes USD 831.79 million size, 13.00% share and 3.20% CAGR, led by herbal teas and oils.
• Nigeria represents USD 639.07 million size, 10.00% share and 3.10% CAGR, reflecting community-based herbal use.

List of Top Herbal Medicine Companies

• Yunnan Baiyao
• Bio-Botanica
• SIDO MUNCUL
• Tsumura
• Schwabe
• Arizona Natural
• Nelsons
• Tasly
• Arkopharma
• Zand
• Blackmores
• Sanjiu
• Tongrentang
• Bionorica
• Herbal Africa
• Nature?s Bounty

Tongrentang – Holds nearly 8% of global market share, with dominance in Asia-Pacific.

Schwabe – Accounts for around 6% share, particularly strong in Europe.

Investment Analysis and Opportunities

Investments in the Herbal Medicine Market are growing steadily as both private equity firms and governments recognize the sector’s long-term potential. Global R&D spending in herbal medicine surpassed USD 4.5 billion in 2024, marking a 25% increase compared to 2020. This investment is heavily concentrated in Asia-Pacific, where more than 60% of herbal patents originate. Opportunities for investors lie in premium and personalized herbal products. The personalized supplements market, of which herbal medicine forms nearly 30%, is expected to reach over 100 million users by 2030. Investment into genetic testing integration with herbal prescriptions has already attracted more than USD 1 billion globally in the past two years.

E-commerce presents another major opportunity. Online sales now account for 35% of global herbal medicine distribution. Venture capital investments in digital health platforms focusing on herbal and natural medicine reached nearly USD 800 million in 2024. Emerging markets, particularly in Africa and Southeast Asia, represent untapped opportunities. With urbanization rising and 70% of the population relying on traditional medicines, there is significant demand for standardized and packaged herbal products. Sustainability is also attracting investors. More than 45% of consumers prefer certified organic herbal medicines, pushing companies to invest in sustainable sourcing. Investors who focus on ESG (Environmental, Social, Governance) portfolios are increasingly funding herbal companies with transparent supply chains.

New Product Development

Innovation is driving the Herbal Medicine Market Growth with a wave of new product developments across capsules, extracts, teas, and functional foods. Between 2023 and 2025, more than 3,500 new herbal products were launched globally. Immunity boosters represent nearly 40% of new launches, followed by mental health supplements at 25%, and digestive health formulations at 20%. A key area of development is herbal-infused beverages. Global consumption of herbal teas and tonics surpassed 600,000 tons annually, with functional herbal drinks generating sales worth more than USD 20 billion. Companies are also integrating adaptogens like ashwagandha and rhodiola into energy drinks and protein powders.

Skin health and cosmetics are another fast-growing category. Herbal cosmetic products contributed nearly USD 30 billion in 2024, representing 13% of the global herbal medicine sector. Innovations in herbal serums, oils, and lotions are expanding the market beyond traditional medicine into mainstream beauty. Standardized extracts are also advancing, with over 60% of new pharmaceutical-grade herbal formulations containing concentrated extracts. Biotechnology is playing a role, with companies using fermentation and bioconversion to enhance bioavailability of herbal compounds. The launch of nanotechnology-based herbal delivery systems is expected to reduce dosage volume by 30% while improving absorption efficiency.

Five Recent Developments

• In 2023, a leading Asian herbal manufacturer launched over 120 new standardized extracts targeting cardiovascular and immunity health.
• In 2024, European herbal companies introduced 45 new herbal cosmetic formulations, increasing cosmetic-based revenue by 15%.
• In 2024, a U.S. company partnered with biotech firms to develop DNA-personalized herbal supplements, enrolling 50,000 customers in the first year.
• In 2025, global e-commerce platforms recorded herbal medicine sales growth of nearly 25%, with over 35% share of total distribution.
• In 2025, a new herbal beverage line using turmeric and ginger extracts sold over 10 million units within its first six months.

Report Coverage of Herbal Medicine Market

This Herbal Medicine Market Research Report covers the complete scope of the industry across global, regional, and segmental levels. The report provides detailed insights into herbal medicine market size, herbal medicine market share, and herbal medicine market growth across major economies. It highlights trends in product forms such as tablets, capsules, powders, extracts, and herbal beverages, analyzing consumption patterns that exceed 20 billion dosage units and 12 million tons of powders annually. The report also analyzes applications, including Western Herbalism, Traditional Chinese Medicine, Ayurveda, Kampo, and African traditional medicine, which collectively influence more than 5 billion consumers worldwide. Regional insights highlight Asia-Pacific’s leadership with 43% share, Europe’s 29%, North America’s 18%, and the Middle East & Africa’s 10%.

Competitive analysis identifies top players, including Tongrentang, Schwabe, Blackmores, Tsumura, and others, who collectively hold around 28% of the market. The report evaluates their product portfolios, R&D pipelines, and investment strategies. Recent developments, such as the introduction of over 3,500 new products between 2023 and 2025, are mapped to understand innovation pipelines. The coverage extends to investment opportunities, sustainability trends, personalized medicine growth, and e-commerce transformation. It provides forecasts and insights into market dynamics such as drivers (62% consumer preference for natural remedies), restraints (37% quality inconsistencies), opportunities (27% demand for personalized formulations), and challenges (18% rise in raw material costs).

Herbal Medicine Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 2037.76 Million in 2026
Market Size Value By	USD 181120.66 Million by 2035
Growth Rate	CAGR of 3.93% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Tablets & Capsules Powders Extracts Others By Application : Western Herbalism Traditional Chinese Medicine Others
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample